Immuno Nano Med
PrivateLast Round
Grant
Nov 19, 2025
Total Funding Raised
$360,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Immuno Nano Med is a biotechnology company developing room-temperature-stable, dry powder influenza vaccines designed to provide broad, needle-free immunity and eliminate global cold chain dependencies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immuno Nano Med Comparables
Compare Immuno Nano Med with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vivaldi Biosciences, Inc. | 77% | |
| Altimmune Inc | 74% | |
| Tff Pharmaceuticals Inc | 71% |
Immuno Nano Med Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 19, 2025 | ||||
| Grant | Oct 1, 2025 | ||||
| Grant | Aug 22, 2025 | ||||
| Accelerator | Aug 22, 2025 |
Immuno Nano Med Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Iowa John Pappajohn Entrepreneurial Center | Grant |
| John Pappajohn Iowa Entrepreneurial Venture Competition | Grant |
| Iowa State University Startup Factory | Accelerator |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 19, 2025
$15K raised from University of Iowa John Pappajohn Entrepreneurial Center.
- Oct 1, 2025
$305K grant awarded by the National Science Foundation.
Immuno Nano Med Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Immuno Nano Med's valuation, stock price, and market status.
Is Immuno Nano Med a public or private company?
Immuno Nano Med is a private company.
What is the current stock price of Immuno Nano Med?
Immuno Nano Med is a private company with no public stock price. No recent secondary market data is available.
How much is Immuno Nano Med worth (valuation)?
Valuation information for Immuno Nano Med is not publicly available.
Can I buy Immuno Nano Med stock?
Immuno Nano Med shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Immuno Nano Med's last funding round?
Immuno Nano Med's most recent funding round was Grant on November 19, 2025.
Who are the main investors in Immuno Nano Med?
Key investors in Immuno Nano Med include University of Iowa John Pappajohn Entrepreneurial Center, John Pappajohn Iowa Entrepreneurial Venture Competition, Iowa State University Startup Factory, National Science Foundation.
Will Immuno Nano Med IPO soon?
No public IPO plans have been announced for Immuno Nano Med.
How can I track Immuno Nano Med secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Immuno Nano Med's secondary market activity and sign up for updates.